| 标题 |
Siplizumab combination therapy with belatacept or abatacept broadly inhibits human T cell alloreactivity in vitro |
| 网址 | |
| DOI | |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)